Laura Senovilla

Instituto de Biomedicina y Genética Molecular de Valladolid — Spain

Medicine · Health Sciences

57h-index14.6kcitations172works5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(36), Autophagy in Disease and Therapy(23), Cancer therapeutics and mechanisms(20), Cancer Immunotherapy and Biomarkers(19), Microtubule and mitosis dynamics(19)

Publications172 total

Glioblastoma: perspectivas terapeúticas futuras
Clínica/Clínica·2025Open Access
Cáncer de mama triple negativo: Del análisis multiómico a la personalización terapéutica
Clínica/Clínica·2025Open Access
Editorial: Cell death in cancer immunology
Frontiers in Oncology·2024Open Access
Mineralocorticoid Receptor and Sleep Quality in Chronic Kidney Disease
International Journal of Molecular Sciences·2024· 1 citedOpen Access
Obesity-Associated Colorectal Cancer
International Journal of Molecular Sciences·2024· 25 citedOpen Access
Multiomics insights on the onset, progression, and metastatic evolution of breast cancer
Frontiers in Oncology·2023· 9 citedOpen Access
Supplementary Figure 2 from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Supplementary Figure 3 from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Supplementary Figure 6 from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Supplementary Table 1 from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Supplementary Table 4 from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Supplementary Video 5 from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Supplementary Video 2 from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Supplementary Table 1, Figures 1 - 8 from Cisplatin Resistance Associated with PARP Hyperactivation
2023Open Access
Supplementary Tables 1-4 from miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
2023Open Access
Supplementary Methods, Legends for Videos and Figures from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Supplementary Video 4 from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Supplementary Video 4 from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Data from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
Supplementary Figure 3 from Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Guido Kroemer(49), Oliver Kepp(31), Lorenzo Galluzzi(30), Laurence Zitvogel(28), Ilio Vitale(17), Erika Vacchelli(15), Maria Castedo(13), Isabelle Martins(10), Sandy Adjemian(8), David Enot(8), Mickaël Michaud(8), Pauline Garcia(8), Judith Michels(7), Jérôme Galon(7), Takahiro Yamazaki(7), Norma Bloy(6), Aitziber Buqué(6), Frank Madeo(6), Guillermo Mariño(6), Wolf H. Fridman(6)